Yissum licenses dry eye candidate to BioLineRx
BioLineRx Ltd. licensed exclusive worldwide rights to Yissum Research Development Co.'s preclinical BL1230 for dry eye syndrome.
- Specialty Pharmaceuticals
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.